IHS Chemical Week

Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

Glenmark Buys Czech Pharma Firm

12:25 PM MDT | July 26, 2007 | DR

Glenmark Pharmaceuticals Ltd.’s (Mumbai) subsidiary Glenmark Holdings (GHSA; La Chaux-de-Fonds, Switzerland) says it has acquired more than a 90% stake in Czech pharmaceutical company Medicamenta (Praha). Terms were not disclosed. Medicamenta’s 2007 projected revenue is $8 million, Glenmark says. Medicamenta has sales and marketing operations in the Czech Republic and Slovakia, and the deal gives Glenmark an entry point into those fast-growing regions, Glenmark says. The transaction is part of Glenmark’s long-term strategy to “emerge as a...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis on chemweek.com
  • Free mobile edition 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Learn more about group subscriptions and site licenses.


contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa